NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Phosphodiesterase Inhibitor


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on enzyme research detailed by researchers at Vanderbilt University
2009 NOV 16 ... Drugs, Enzymes, Experimental Therapies, Glutamine, Pharmaceuticals, Pharmacology, Phosphodiesterase Inhibitor, Phosphodiesterases, Sildenafil, Tadalafil, Therapy, Treatment, Vasodilator Agent, ...
Subject: Enzyme Research
Price: $3.00
*
Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development
2009 NOV 16 ... the safety and efficacy of udenafil, an orally administered selective inhibitor of phosphodiesterase versus placebo. The trials will be conducted in 80 sites in the U.S. and will enroll ...
Subject: Erectile Dysfunction
Price: $3.00
*
FDA Warns Consumers on Sexual Enhancement Products
2009 NOV 16 ... Keywords: , U.S. Food and Drug Administration, FDA, Regulatory Actions, Sildenafil, Phosphodiesterase Inhibitor, Vasodilator Agent, Sildenafil Citrate, Viagra, Pharmaceuticals, Drugs, Therapy, ...
Subject: U.S. Food and Drug Administration
Price: $3.00
*
Investigators at Kanazawa University publish new data on osteosarcoma
2009 NOV 16 ... System Stimulant, Chemotherapy, Drug Therapy, Oncology, Orthopedics, Osteosarcoma, Phosphodiesterase Inhibitor, Pulmonology, Sarcoma, Soft Tissue Sarcoma, Therapy, Treatment, Kanazawa University. ...
Subject: Osteosarcoma
Price: $3.00
*
New blood pressure study findings have been published by scientists at Skidmore College
2009 NOV 16 ... Caffeine, Cardiology, Cardiovascular, Central Nervous System Stimulant, Metabolism, Phosphodiesterase Inhibitor, Therapy, Treatment, Skidmore College. This article was prepared by Biotech ...
Subject: Blood Pressure
Price: $3.00
*
New DNA research study results from Shanghai Institute of Materia Medica, Research Division described
2009 NOV 23 ... Genetics, Genomics, Neoplasia, Neurology, Oncology, Pharmaceuticals, Pharmacological, Phosphodiesterase Inhibitor, Proteomics, Topoisomerase, Treatment. This article was prepared by Pain & ...
Subject: DNA Research
Price: $3.00
*
New findings from University of Cambridge in the area of pharmaceuticals described
2009 NOV 16 ... Drugs, Experimental Pharmacology, Pharmaceuticals, Pharmacological, Pharmacology, Phosphodiesterase Inhibitor, Physiology, Therapy, Treatment. This article was prepared by Biotech ...
Subject: Pharmaceuticals
Price: $3.00
*
New hypertension study findings have been published by M. Samarzija and colleagues
2009 NOV 23 ... Zagreb, Croatia. Keywords: City:Zagreb, Country:Croatia, Hypertension, Phosphodiesterase Inhibitor, Sildenafil, Vasodilator Agent. This article was prepared by Biotech ...
Subject: Hypertension
Price: $3.00
*
New life sciences study findings have been reported from Harvard University, Medical Department
2009 NOV 23 ... Health Policy, Erectile Dysfunction, Impotence, Regulatory Actions, Sildenafil, Phosphodiesterase Inhibitor, Vasodilator Agent, Public Health, Harvard University, Medical Department. ...
Subject: Life Sciences
Price: $3.00
*
Reports from Seoul National University highlight recent research in pharmacology and toxicology
2009 NOV 10 ... Alternative Medicine, Caffeine, Anorexigenic Agent, Central Nervous System Stimulant, Phosphodiesterase Inhibitor, Dextromethorphan, Analgesic, Antitussive, Excitatory Amino Acid Antagonist, Losartan, ...
Subject: Pharmacology and Toxicology
Price: $3.00
*
Research from University of London, Imperial College in the area of pulmonary hypertension published
2009 NOV 23 ... Keywords: City:London, Country:United Kingdom, Drugs, Enzymes, Pharmaceuticals, Phosphodiesterase Inhibitor, Phosphodiesterases, Pulmonary Hypertension, Pulmonology, Sildenafil, Simvastatin, ...
Subject: Pulmonary Hypertension
Price: $3.00
*
Research in the area of sclerosis reported from University of Michigan
2009 NOV 23 ... tolerability, and efficacy of tadalafil, a selective, long acting, type V cyclic GMP phosphodiesterase (PDE-5) inhibitor, in this clinical syndrome," scientists writing in the Journal of ...
Subject: Sclerosis
Price: $3.00
*
Studies from A. Muller et al in the area of prostatectomy described
2009 NOV 9 ... United States, New York, Nerve Injury, Oncology, Pharmaceuticals, Pharmacological, Phosphodiesterase Inhibitor, Prostate Cancer, Prostatectomy, Prostatic Neoplasms, Rehabilitation Research, ...
Subject: Prostatectomy
Price: $3.00
*
Studies from E. Rubioaurioles and co-researchers yield new data on erectile dysfunction
2009 NOV 9 ... Drugs, Enzyme Research, Enzymology, Erectile Dysfunction, Impotence, Pharmaceuticals, Phosphodiesterase Inhibitor, Phosphodiesterases, Sildenafil Citrate, Tadalafil, Therapy, Treatment, Vasodilator ...
Subject: Erectile Dysfunction
Price: $3.00
*
Studies from University of Cagliari have provided new data on enzyme research
2009 NOV 9 ... Dysfunction, Impotence, Microdialysis, Microtechnology, Nitric Oxide, Pharmaceuticals, Phosphodiesterase Inhibitor, Phosphodiesterases, Sildenafil, Tadalafil, Therapy, Treatment, Vardenafil, ...
Subject: Enzyme Research
Price: $3.00
*
Study results from Hokkaido University update understanding of glycogen storage disease
2009 NOV 16 ... Japan. Keywords: Japan, Sapporo, Glycogen Storage Disease, Hypertension, Phosphodiesterase Inhibitor, Sildenafil, Syncope, Vasodilator Agent, Hokkaido University. This article ...
Subject: Glycogen Storage Disease
Price: $3.00
*
Study results from Northumbria University provide new insights into hypoglycemia
2009 NOV 16 ... Physiology, Caffeine, Central Nervous System Stimulant, Hypoglycemia, Metabolism, Phosphodiesterase Inhibitor, Therapy, Treatment, Northumbria University. This article was prepared by ...
Subject: Hypoglycemia
Price: $3.00
*
Teeth Grinding Linked to Sleep Apnea
2009 NOV 16 ... Reflux, Gastrointestinal Reflux Disease, Obstructive Sleep Apnea, Otolaryngology, Phosphodiesterase Inhibitor, Pulmonology, Sleep Disorders, Snoring, TMJ, Temporomandibular Joint Dysfunction ...
Subject: Gastrointestinal Reflux Disease
Price: $3.00
*
Tongji University details research in hypertension
2009 NOV 16 ... Keywords: People's Republic of China, Shanghai, Cardiology, Enzymes, Hypertension, Phosphodiesterase Inhibitor, Phosphodiesterases, Sildenafil, Vasodilator Agent, Tongji University. This ...
Subject: Hypertension
Price: $3.00
*
U.S. People Foods and Beverages Introduces Dr. Chao "Lady Herbal Drink" and "Adult Herbal Drink"
2009 NOV 9 ... Fatigue Syndrome, Endocrine, Gastroenterology, Hepatology, Hormones, Liver Function, Phosphodiesterase Inhibitor, Virology This article was prepared by Pain & Central Nervous System Week ...
Subject: U.S. People Foods and Beverages, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login